The Paper of the Year Award is designed to honor the most impactful paper in the field of oligonucleotide therapeutics.
Nominations are open and the winner will be announced during the Annual Meeting.
Nomination Deadline: July 9, 2018
The recipient receives:
- $1,000 award
- Complimentary registration to the OTS Annual Meeting
- Formal presentation of the award at the OTS Annual Meeting
- Short talk speaking slot at the OTS Annual Meeting
- Paper must have been published between
July 2017-June 2018
- Paper must be on a topic relevant to oligonucleotide therapeutics
To submit a nomination for the Paper of the Year award, complete the following form.
2017 Paper of the Year Award Winner:
Author: Richard Finkel, MD,
Nemours Children’s Hospital
Talk Title: Treatment of Infantile-onset Spinal Muscular Atrophy with Nusinersen: a Phase 2, Open-label, Dose-escalation Study
Biography: Richard S. Finkel, MD is Professor of Neurology at the University of Central Florida School of Medicine, and Chief, Division of Neurology at Nemours Children’s Hospital in Orlando, USA. He received his medical degree from Washington University School of Medicine in St. Louis, and completed his Pediatrics, Neurology and Neuromuscular training at Boston Children’s Hospital and Harvard Medical School in Boston. Clinical practice and research interests have focused upon pediatric neuromuscular disorders, especially spinal muscular atrophy, Duchenne muscular dystrophy, inherited neuropathies and neurometabolic disorders. Dr. Finkel has participated in numerous clinical trials, natural history genotype-phenotype studies, development of outcome measures, clinical trial design, standard-of-care topics and biomarker identification for neuromuscular disorders. Interest in SMA has included a focus on infants with type I – from natural history studies and the development of the CHOP INTEND motor scale to clinical trial topics and ethical issues. He has published over 120 peer reviewed manuscripts and book chapters and is an associate editor of neuromuscular journals and a pediatric neurology textbook. Dr. Finkel is a Fellow of the American Academy of Pediatrics and the American Neurological Association, and is a member of the World Muscle Society, TREAT-NMD, American Academy of Neurology and Child Neurology Society. He serves as an advisor to Cure SMA, SMA Foundation and SMA Europe.
Past Paper of Year Award Recipients:
- 2016: Paper: Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides
Authors: William “Wes” Salomon, Samson Jolly, Victor Serebrov, Melissa Moore, Phillip Zamore – RNA Therapeutics Institute, University of Massachusetts Medical Center
Presenter: Victor Serebrov, PhD RNA Therapeutics Institute, University of Massachusetts Medical Center –